Cargando…
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
BACKGROUND: Understanding how booster vaccination can prevent moderate and severe illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters. METHODS: We followed 85 801 participants (aged 31–81 years) in 2 large population-based cohorts during the Omicron BA.1/2 wave...
Autores principales: | Laake, Ida, Skodvin, Siri N, Blix, Kristine, Caspersen, Ida Henriette, Gjessing, Håkon K, Juvet, Lene K, Magnus, Per, Mjaaland, Siri, Robertson, Anna H, Starrfelt, Jostein, Trogstad, Lill, Feiring, Berit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620770/ https://www.ncbi.nlm.nih.gov/pubmed/36259543 http://dx.doi.org/10.1093/infdis/jiac419 |
Ejemplares similares
-
Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women
por: Blix, Kristine, et al.
Publicado: (2023) -
Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway
por: Caspersen, Ida Henriette, et al.
Publicado: (2023) -
Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021) -
Covid-19 vaccines and menstrual changes
por: Trogstad, Lill, et al.
Publicado: (2022) -
Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study
por: Laake, Ida, et al.
Publicado: (2018)